The Morning Brief: Citadel Funds Book Gains in January; Tudor Jones Advance; Starboard Seeks Poison Pill Exemption from Wausau

This just in: Citadel numbers are looking good. According to an email sent to this columnist, Citadel’s Kensington and Wellington funds, headed by Ken Griffin, rose 3.25 percent, while its Tactical vehicle rose 2.25 percent and its global equity fund gained just 0.85 percent.

Separately, Paul Tudor Jones’s Tudor BVI was up 3.88 percent through January 25; Moore Global Investment was 2.66 percent higher through January 24; and Caxton Global Investment was up 2.58 percent through January 29, according to an industry source.

Meanwhile the average hedge fund was up 1.61 percent in January, according to the Dow Jones Credit Suisse Core Hedge Fund Index. Long-short equity fared the best, with a 2.14 percent rise, followed by event-driven funds, which climbed 2.05 percent, according to a press release Tuesday. Bringing up the rear, global macro was up 1.10 percent. Several multi-strategy and macro funds did much better than average for the month.


•••

Activist hedge fund Starboard Value has asked Wausau Paper to grant it an exemption so it can increase its stake in the Mosinee, Wisconsin, paper products company, from its current 14.8 percent to above the magic level of 15 percent. That increase would otherwise trigger Wausau’s poison pill. If the exemption is granted it would permit Starboard to own up to 19.99 percent of the outstanding shares. Starboard, Wausau’s largest shareholder, says in a regulatory filing Tuesday that Wausau has maintained its pill for more than 14 years, yet it has never submitted it for approval by shareholders. Starboard says Wausau does not need the takeover defense since there are certain anti-takeover provisions under both Wisconsin law and the company’s articles of incorporation that enable it to prevent potential abusive tactics by third parties to gain control.


•••

Sponsored

Good news for those hedge funds who still hold Apple shares, after the market drubbing in recent weeks. The iPad, iPhone and iPod maker’s stock climbed 3.51 percent, as investors swooped in on what they perceived as an undervalued stock. Shares closed at $457.82 Tuesday.

Related